MSS-21613-37775 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-26
Dose 1 — Pfizer-BioNTech
2021-07-21
Dose 2 — Pfizer-BioNTech
2022-01-10
Registered in v-safe
2022-01-10
Dose 3 — Moderna
2022-01-10
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · Chills, Fatigue or tiredness

Adult check-in
2022-01-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2022-01-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-01-13
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Swollen lymph node near collarbone

MedDRA releases: 2024-11 · check-in free text available
2022-01-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-01-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-16
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-17
Health check-in — day 7, dose 3
Feeling: Good · Headache

Adult check-in
2022-01-24
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-02
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-07
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-14
Survey response — day 35, dose 3
MedDRA: Palpitations, Ventricular extrasystoles — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: PVC heart palpitations

MedDRA releases: 2024-11 · check-in free text available
2022-02-14
Report sent to call center — day 35, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-17
Call 1 — Left Voicemail
2022-02-21
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-11
Survey response — 3 months, dose 3
MedDRA: Bradycardia, Postpartum state — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Symptomatic Postpartum Bradycardia

MedDRA releases: 2024-11 · check-in free text available
2022-04-11
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-04-12
Call 1 — Left Voicemail
2022-07-11
Survey response — 6 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid

MedDRA releases: 2024-11 · check-in free text available
2022-07-11
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-07-12
Call 2 — Left Voicemail
2022-07-12
Call 2 — Left Voicemail
2022-07-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-26	Pfizer-BioNTech	No
2	2021-07-21	Pfizer-BioNTech	No
3	2022-01-10	Moderna	No

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2022-01-13

Systemic reaction (other): Swollen lymph node near collarbone

Release 11 — day 35, dose 3

2022-02-14

Symptoms: PVC heart palpitations

Release 11 — 3 months, dose 3

2022-04-11

Symptoms: Symptomatic Postpartum Bradycardia

Release 12 — 6 months, dose 3

2022-07-11

Symptoms: Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bradycardia	·	·	✓
SD	COVID-19	·	·	✓
SD	Palpitations	·	·	✓
SD	Postpartum state	·	·	✓
SD	Ventricular extrasystoles	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release